Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06962345Not ApplicableRecruiting

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Role: collaborator

NCT06730464Recruiting

Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy

Role: collaborator

NCT05933876Recruiting

The Impact of Radiotherapy on Oligometastatic Cancer

Role: collaborator

NCT04204954Phase 2Completed

Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery

Role: lead

NCT03831984Phase 4Unknown

Topical Bromfenac for Intraoperative Miosis and Pain Reduction

Role: lead

All 5 trials loaded